ReviewDrug, healthcare and patient safety2022

Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Rupesh Raina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.